Suppression of dendritic cells' maturation and functions by daidzein, a phytoestrogen

Toxicology and Applied Pharmacology

Volumn 257, Issue 2, 2011, Pages 174-181

  Yum, Min Kyu ^a   Jung, Mi Young ^a   Cho, Daeho ^b   Kim, Tae Sung ^a  

^a Korea University   (South Korea)

^b Sookmyung Women's University   (South Korea)

Author keywords

Daidzein; Dendritic cell; Immunosuppression; Maturation

Indexed keywords

B7 ANTIGEN; BIOCHANIN A; CD40 ANTIGEN; CD86 ANTIGEN; DAIDZEIN; EQUOL; FORMONONETIN; GENISTEIN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFECT; ENDOCYTOSIS; FEMALE; IMMUNOMODULATION; MOUSE; NONHUMAN;

ANIMALS; CELL ENLARGEMENT; DENDRITIC CELLS; FEMALE; GROWTH INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; ISOFLAVONES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHYTOESTROGENS;

EID: 81855175348     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.09.002     Document Type: Article

References (39)

1. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995, 270:286-290.
2. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
3. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
4. Barnes S. The biochemistry, chemistry and physiology of the isoflavones in soybeans and their food products. Lymphat. Res. Biol. 2010, 8:89-98.
5. Carreno B.M., Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 2002, 20:29-53.
6. de Jong E.C., Smits H.H., Kapsenberg M.L. Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 2005, 26:289-307.
7. Di Giacinto C., Marinaro M., Sanchez M., Strober W., Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J. Immunol. 2005, 174:3237-3246.
8. Dixon R.A. Phytoestrogens. Annu. Rev. Plant Biol. 2004, 55:225-261.
9. Dong X., Lutz W., Schroeder T.M., Bachman L.A., Westendorf J.J., Kumar R., Griffin M.D. Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:16007-16012.
10. Fatehi M., Anvari K., Fatehi-Hassanabad Z. The beneficial effects of protein tyrosine kinase inhibition on the circulatory failure induced by endotoxin in the rat. Shock 2002, 18:450-455.
11. Feldmann M., Maini R.N. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?. Annu. Rev. Immunol. 2001, 19:163-196.
12. Greten F.R., Arkan M.C., Bollrath J., Hsu L.C., Goode J., Miething C., Goktuna S.I., Neuenhahn M., Fierer J., Paxian S., Van Rooijen N., Xu Y., O'Cain T., Jaffee B.B., Busch D.H., Duyster J., Schmid R.M., Eckmann L., Karin M. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 2007, 130:918-931.
13. Guermonprez P., Valladeau J., Zitvogel L., Thery C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 2002, 20:621-667.
14. Hamalainen M., Nieminen R., Vuorela P., Heinonen M., Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007, doi:10.1155/2007/45673.
15. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
16. Hendriks J.J., Alblas J., van der Pol S.M., van Tol E.A., Dijkstra C.D., de Vries H.E. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J. Exp. Med. 2004, 200:1667-1672.
17. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992, 176:1693-1702.
18. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 2003, 3:984-993.
19. Kawaguchi K., Kikuchi S., Hasunuma R., Maruyama H., Yoshikawa T., Kumazawa Y. A citrus flavonoid hesperidin suppresses infection-induced endotoxin shock in mice. Biol. Pharm. Bull. 2004, 27:679-683.
20. Kim J.W., Jin Y.C., Kim Y.M., Rhie S., Kim H.J., Seo H.G., Lee J.H., Ha Y.L., Chang K.C. Daidzein administration in vivo reduces myocardial injury in a rat ischemia/reperfusion model by inhibiting NF-kappaB activation. Life Sci. 2009, 84:227-234.
21. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995, 86:1243-1254.
22. Maini R.N., Taylor P.C., Szechinski J., Pavelka K., Broll J., Balint G., Emery P., Raemen F., Petersen J., Smolen J., Thomson D., Kishimoto T. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum. 2006, 54:2817-2829.
23. Morimoto M., Watanabe T., Yamori M., Takebe M., Wakatsuki Y. Isoflavones regulate innate immunity and inhibit experimental colitis. J. Gastroenterol. Hepatol. 2009, 24:1123-1129.
24. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
25. Piemonti L., Monti P., Allavena P., Sironi M., Soldini L., Leone B.E., Socci C., Di Carlo V. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 1999, 162:6473-6481.
26. Piemonti L., Monti P., Sironi M., Fraticelli P., Leone B.E., Dal Cin E., Allavena P., Di Carlo V. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 2000, 164:4443-4451.
27. Ross J.A., Kasum C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 2002, 22:19-34.
28. Sakai T., Kogiso M. Soy isoflavones and immunity. J. Med. Invest. 2008, 55:167-173.
29. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 1995, 182:389-400.
30. Scheinman R.I., Cogswell P.C., Lofquist A.K., Baldwin A.S. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995, 270:283-286.
31. Sheu F., Lai H.H., Yen G.C. Suppression effect of soy isoflavones on nitric oxide production in RAW 264.7 macrophages. J. Agric. Food Chem. 2001, 49:1767-1772.
32. Szeto F.L., Sun J., Kong J., Duan Y., Liao A., Madara J.L., Li Y.C. Involvement of the vitamin D receptor in the regulation of NF-kappaB activity in fibroblasts. J. Steroid Biochem. Mol. Biol. 2007, 103:563-566.
33. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3:133-146.
34. Vanden Berghe W., Dijsselbloem N., Vermeulen L., Ndlovu N., Boone E., Haegeman G. Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-kappaB gene expression by soy isoflavones does not require estrogenic activity. Cancer Res. 2006, 66:4852-4862.
35. Victor F.C., Gottlieb A.B., Menter A. Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis. Clin. Dermatol. 2003, 21:392-397.
36. Wang W., Higuchi C.M., Zhang R. Individual and combinatory effects of soy isoflavones on the in vitro potentiation of lymphocyte activation. Nutr. Cancer 1997, 29:29-34.
37. Xu X., Harris K.S., Wang H.J., Murphy P.A., Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr. 1995, 125:2307-2315.
38. Yasukawa H., Ohishi M., Mori H., Murakami M., Chinen T., Aki D., Hanada T., Takeda K., Akira S., Hoshijima M., Hirano T., Chien K.R., Yoshimura A. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 2003, 4:551-556.
39. Zhang R., Li Y., Wang W. Enhancement of immune function in mice fed high doses of soy daidzein. Nutr. Cancer 1997, 29:24-28.